| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | AKAP5 SPATA31A1 SPATA31A3 MAP1B MAP2 PSG1 PSG5 PSG9 SPATA31A7 PPP1R9A DMD EPB41L2 | 4.02e-08 | 479 | 65 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DLG5 AKAP5 SPATA31A1 SPATA31A3 MAP1B MAP2 PSG1 PSG5 PSG9 SPATA31A7 PPP1R9A CKAP5 DMD EPB41L2 BICD1 | 1.81e-06 | 1099 | 65 | 15 | GO:0008092 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.17e-05 | 14 | 65 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 5.57e-05 | 23 | 65 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | cytoskeletal regulatory protein binding | 1.04e-04 | 5 | 65 | 2 | GO:0005519 | |
| GeneOntologyMolecularFunction | filamin binding | 1.13e-04 | 29 | 65 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.13e-04 | 29 | 65 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.83e-04 | 34 | 65 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | protein kinase binding | 4.89e-04 | 873 | 65 | 10 | GO:0019901 | |
| GeneOntologyMolecularFunction | glycolipid binding | 5.45e-04 | 49 | 65 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 5.65e-04 | 316 | 65 | 6 | GO:0035091 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 6.07e-04 | 210 | 65 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 6.74e-04 | 12 | 65 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | calmodulin binding | 9.14e-04 | 230 | 65 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | kinase binding | 1.09e-03 | 969 | 65 | 10 | GO:0019900 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.54e-03 | 70 | 65 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.68e-03 | 264 | 65 | 5 | GO:0019902 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.74e-03 | 73 | 65 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.98e-03 | 548 | 65 | 7 | GO:0005543 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.44e-03 | 173 | 65 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 2.75e-03 | 24 | 65 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.16e-03 | 90 | 65 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase kinase binding | 3.22e-03 | 26 | 65 | 2 | GO:0031435 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 4.00e-03 | 29 | 65 | 2 | GO:0035035 | |
| GeneOntologyMolecularFunction | lipid binding | 4.53e-03 | 988 | 65 | 9 | GO:0008289 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.06e-05 | 14 | 65 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.32e-05 | 15 | 65 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.32e-05 | 15 | 65 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.32e-05 | 15 | 65 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.32e-05 | 15 | 65 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.33e-05 | 46 | 65 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.33e-05 | 46 | 65 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.62e-05 | 16 | 65 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.71e-05 | 49 | 65 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.97e-05 | 17 | 65 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.97e-05 | 17 | 65 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.97e-05 | 17 | 65 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.36e-05 | 18 | 65 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.28e-05 | 20 | 65 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.81e-05 | 21 | 65 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.81e-05 | 21 | 65 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.81e-05 | 21 | 65 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.41e-05 | 22 | 65 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.06e-05 | 23 | 65 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.06e-05 | 23 | 65 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 5.59e-05 | 66 | 65 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 5.77e-05 | 24 | 65 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 5.77e-05 | 24 | 65 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 5.77e-05 | 24 | 65 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 6.54e-05 | 25 | 65 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 6.54e-05 | 25 | 65 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 8.28e-05 | 27 | 65 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 8.30e-05 | 73 | 65 | 4 | GO:0042304 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 9.02e-05 | 337 | 65 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 9.25e-05 | 28 | 65 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.03e-04 | 29 | 65 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.26e-04 | 31 | 65 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | 1.31e-04 | 358 | 65 | 7 | GO:0071900 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.39e-04 | 32 | 65 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.39e-04 | 32 | 65 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.39e-04 | 32 | 65 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.52e-04 | 33 | 65 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.52e-04 | 33 | 65 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 1.64e-04 | 87 | 65 | 4 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.67e-04 | 34 | 65 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.67e-04 | 34 | 65 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.82e-04 | 35 | 65 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 2.04e-04 | 171 | 65 | 5 | GO:0050868 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.33e-04 | 38 | 65 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 2.46e-04 | 178 | 65 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 2.52e-04 | 39 | 65 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 2.70e-04 | 8 | 65 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 2.72e-04 | 40 | 65 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.92e-04 | 41 | 65 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 3.14e-04 | 42 | 65 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 3.49e-04 | 192 | 65 | 5 | GO:1903038 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 3.63e-04 | 107 | 65 | 4 | GO:0042130 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.86e-04 | 45 | 65 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.39e-04 | 47 | 65 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 4.39e-04 | 47 | 65 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 4.39e-04 | 47 | 65 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | liver development | 4.40e-04 | 202 | 65 | 5 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.70e-04 | 205 | 65 | 5 | GO:0061008 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 4.96e-04 | 49 | 65 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 5.27e-04 | 50 | 65 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | semicircular canal development | 5.28e-04 | 11 | 65 | 2 | GO:0060872 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 5.36e-04 | 211 | 65 | 5 | GO:0051250 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 5.91e-04 | 52 | 65 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 6.25e-04 | 53 | 65 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 6.35e-04 | 124 | 65 | 4 | GO:0050672 | |
| GeneOntologyBiologicalProcess | dendrite development | 6.48e-04 | 335 | 65 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 6.74e-04 | 126 | 65 | 4 | GO:0032945 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 7.35e-04 | 56 | 65 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 8.48e-04 | 134 | 65 | 4 | GO:0019217 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 8.48e-04 | 134 | 65 | 4 | GO:0070664 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 8.56e-04 | 59 | 65 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | PIKFYVE MAP1B MAP2 DDHD1 PPP1R9A MKI67 CKAP5 PLA2G4A CGNL1 HNRNPC MFN1 BICD1 | 8.84e-04 | 1342 | 65 | 12 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 8.88e-04 | 236 | 65 | 5 | GO:0042129 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 8.98e-04 | 493 | 65 | 7 | GO:0007018 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 8.99e-04 | 60 | 65 | 3 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 8.99e-04 | 60 | 65 | 3 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 9.44e-04 | 61 | 65 | 3 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 9.57e-04 | 240 | 65 | 5 | GO:0002695 | |
| GeneOntologyBiologicalProcess | endocytosis | 1.09e-03 | 827 | 65 | 9 | GO:0006897 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.13e-03 | 249 | 65 | 5 | GO:0007565 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.14e-03 | 145 | 65 | 4 | GO:0001578 | |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 1.16e-03 | 375 | 65 | 6 | GO:0001933 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 1.19e-03 | 66 | 65 | 3 | GO:0007019 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 1.19e-03 | 252 | 65 | 5 | GO:0022408 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 1.21e-03 | 253 | 65 | 5 | GO:0099111 | |
| GeneOntologyBiologicalProcess | cranial nerve development | 1.24e-03 | 67 | 65 | 3 | GO:0021545 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.24e-03 | 67 | 65 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 1.29e-03 | 17 | 65 | 2 | GO:0036159 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 1.32e-03 | 151 | 65 | 4 | GO:1902106 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 1.35e-03 | 69 | 65 | 3 | GO:0031113 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.35e-03 | 69 | 65 | 3 | GO:0030195 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 1.41e-03 | 70 | 65 | 3 | GO:0060999 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.41e-03 | 70 | 65 | 3 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.41e-03 | 70 | 65 | 3 | GO:1900047 | |
| GeneOntologyBiologicalProcess | nose development | 1.45e-03 | 18 | 65 | 2 | GO:0043584 | |
| GeneOntologyBiologicalProcess | intracellular mRNA localization | 1.45e-03 | 18 | 65 | 2 | GO:0008298 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 1.46e-03 | 264 | 65 | 5 | GO:0050866 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.47e-03 | 71 | 65 | 3 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.47e-03 | 71 | 65 | 3 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 1.47e-03 | 694 | 65 | 8 | GO:0002694 | |
| GeneOntologyCellularComponent | cilium | CEP170 DLG5 CABYR IMPG1 MAP1B PSG1 PSG5 PSG9 GLI3 PKD1L1 CEP126 DNAH7 CCDC39 GARIN2 | 6.35e-07 | 898 | 66 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.63e-05 | 16 | 66 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | cell projection membrane | 6.17e-05 | 431 | 66 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.89e-04 | 90 | 66 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 2.62e-04 | 98 | 66 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | basal dendrite | 4.35e-04 | 10 | 66 | 2 | GO:0097441 | |
| GeneOntologyCellularComponent | nuclear body | 5.05e-04 | 903 | 66 | 10 | GO:0016604 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.40e-04 | 451 | 66 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | filopodium | 6.21e-04 | 123 | 66 | 4 | GO:0030175 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.51e-04 | 477 | 66 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.02e-03 | 503 | 66 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.28e-03 | 523 | 66 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.54e-03 | 157 | 66 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | filopodium membrane | 1.98e-03 | 21 | 66 | 2 | GO:0031527 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.06e-03 | 170 | 66 | 4 | GO:1902911 | |
| MousePheno | abnormal muscle triglyceride level | 1.07e-05 | 36 | 54 | 4 | MP:0031412 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.57e-05 | 17 | 54 | 3 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 6.90e-05 | 21 | 54 | 3 | MP:0031415 | |
| MousePheno | abnormal incidence of induced tumors | 7.39e-05 | 269 | 54 | 7 | MP:0013151 | |
| MousePheno | decreased fatty acid oxidation | 1.04e-04 | 24 | 54 | 3 | MP:0014172 | |
| MousePheno | abnormal carbon dioxide production | 1.27e-04 | 67 | 54 | 4 | MP:0008962 | |
| MousePheno | increased abdominal fat pad weight | 1.49e-04 | 27 | 54 | 3 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.67e-04 | 28 | 54 | 3 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 2.27e-04 | 31 | 54 | 3 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 2.27e-04 | 31 | 54 | 3 | MP:0008964 | |
| MousePheno | abnormal third ventricle morphology | 2.30e-04 | 78 | 54 | 4 | MP:0000826 | |
| MousePheno | decreased susceptibility to Riboviria infection | 2.78e-04 | 82 | 54 | 4 | MP:0020914 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 3.27e-04 | 35 | 54 | 3 | MP:0031618 | |
| Domain | DUF4599 | 7.23e-04 | 12 | 63 | 2 | PF15371 | |
| Domain | DUF4599 | 7.23e-04 | 12 | 63 | 2 | IPR027970 | |
| Domain | Ig_2 | 1.92e-03 | 73 | 63 | 3 | PF13895 | |
| Domain | FHA | 4.00e-03 | 28 | 63 | 2 | SM00240 | |
| Domain | FHA_DOMAIN | 4.89e-03 | 31 | 63 | 2 | PS50006 | |
| Domain | FHA | 4.89e-03 | 31 | 63 | 2 | PF00498 | |
| Domain | Helicase_C | 5.66e-03 | 107 | 63 | 3 | PF00271 | |
| Domain | HELICc | 5.66e-03 | 107 | 63 | 3 | SM00490 | |
| Domain | Helicase_C | 5.81e-03 | 108 | 63 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 5.96e-03 | 109 | 63 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.96e-03 | 109 | 63 | 3 | PS51192 | |
| Domain | DEXDc | 5.96e-03 | 109 | 63 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.11e-03 | 110 | 63 | 3 | IPR014001 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.20e-03 | 35 | 63 | 2 | IPR002464 | |
| Domain | FHA_dom | 6.55e-03 | 36 | 63 | 2 | IPR000253 | |
| Domain | - | 6.55e-03 | 36 | 63 | 2 | 2.60.200.20 | |
| Domain | DEAH_ATP_HELICASE | 7.28e-03 | 38 | 63 | 2 | PS00690 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP170 NOLC1 EHBP1 DLG5 MAP1B MAP2 TEX2 PRRC2C CCDC18 CKAP5 BOD1L1 CGNL1 DNAH7 SNX2 EPB41L2 | 7.45e-11 | 861 | 67 | 15 | 36931259 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CEP170 CDC37 NOLC1 EHBP1 MAP1B CDK12 PRRC2C STEEP1 DDX42 MKI67 CKAP5 BOD1L1 CGNL1 HSPA4 EPB41L2 | 2.30e-10 | 934 | 67 | 15 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BLM CEP170 NOLC1 MAP1B BAZ2B CDK12 PRRC2C ZNF644 STEEP1 DDX42 MKI67 BOD1L1 CHD7 DGCR8 HNRNPC | 3.07e-10 | 954 | 67 | 15 | 36373674 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.62e-09 | 256 | 67 | 9 | 33397691 | |
| Pubmed | Regulation of the epithelial adhesion molecule CEACAM1 is important for palate formation. | 2.25e-08 | 16 | 67 | 4 | 23613893 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BLM NOLC1 CDK12 ZNF644 MKI67 CKAP5 PLA2G4A CHD7 PRG4 HNRNPC SNX2 EPB41L2 | 2.65e-08 | 774 | 67 | 12 | 15302935 |
| Pubmed | BLM CEP170 NOLC1 MAP1B PRRC2C DDX42 MKI67 CKAP5 CHD7 HSPA4 EPB41L2 | 4.66e-08 | 653 | 67 | 11 | 22586326 | |
| Pubmed | 1.30e-07 | 24 | 67 | 4 | 34233187 | ||
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.36e-07 | 6 | 67 | 3 | 25930072 | |
| Pubmed | 2.05e-07 | 216 | 67 | 7 | 31519766 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 2.38e-07 | 7 | 67 | 3 | 7794280 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP170 NOLC1 MAP1B PPP1R9A DDX42 MKI67 CKAP5 CKAP2L HSPA4 HNRNPC SNX2 EPB41L2 | 5.38e-07 | 1024 | 67 | 12 | 24711643 |
| Pubmed | BLM CDC37 NOLC1 CASP8AP2 DLG5 AKAP5 MAP2 TEX2 ZNF644 DDX42 CCDC18 HSPA4 SNX2 EPB41L2 | 7.49e-07 | 1487 | 67 | 14 | 33957083 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.26e-06 | 283 | 67 | 7 | 30585729 | |
| Pubmed | CEP170 PIKFYVE CDC37 CDK12 TEX2 DDHD1 DDX42 RNF213 BOD1L1 CHD7 | 1.37e-06 | 733 | 67 | 10 | 34672954 | |
| Pubmed | 1.43e-06 | 568 | 67 | 9 | 37774976 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.75e-06 | 582 | 67 | 9 | 20467437 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | BLM CEP170 NOLC1 MAP1B CDK12 PRRC2C MKI67 CKAP5 CKAP2L DGCR8 | 1.87e-06 | 759 | 67 | 10 | 35915203 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.90e-06 | 588 | 67 | 9 | 38580884 | |
| Pubmed | 1.92e-06 | 191 | 67 | 6 | 31177093 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.93e-06 | 13 | 67 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.93e-06 | 13 | 67 | 3 | 1985902 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 10964771 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.93e-06 | 13 | 67 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.93e-06 | 13 | 67 | 3 | 16638824 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 20044046 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 32150576 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 22469976 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.93e-06 | 13 | 67 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.93e-06 | 13 | 67 | 3 | 28035001 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.93e-06 | 13 | 67 | 3 | 12832451 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.93e-06 | 13 | 67 | 3 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.93e-06 | 13 | 67 | 3 | 21670291 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.93e-06 | 13 | 67 | 3 | 23935487 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 2702644 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 8380065 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 1279194 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 15331748 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.93e-06 | 13 | 67 | 3 | 22406619 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 7628460 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 25724769 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.93e-06 | 13 | 67 | 3 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.93e-06 | 13 | 67 | 3 | 22092845 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 11801635 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 28913658 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 19008452 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.93e-06 | 13 | 67 | 3 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.93e-06 | 13 | 67 | 3 | 8500759 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.93e-06 | 13 | 67 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.93e-06 | 13 | 67 | 3 | 23800882 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 15207636 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 19285068 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 21760897 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.93e-06 | 13 | 67 | 3 | 1326665 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 21081647 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.93e-06 | 13 | 67 | 3 | 39168268 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 11483763 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 8402684 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 2164599 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 16619040 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.93e-06 | 13 | 67 | 3 | 8209741 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.93e-06 | 13 | 67 | 3 | 21949477 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 29396368 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 26219866 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 18003729 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 26284027 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 2133556 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.93e-06 | 13 | 67 | 3 | 33352461 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 19406938 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 38381498 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 20739537 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.93e-06 | 13 | 67 | 3 | 29967450 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.93e-06 | 13 | 67 | 3 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.93e-06 | 13 | 67 | 3 | 27695943 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 20404914 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 16680193 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 26911181 | ||
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.93e-06 | 13 | 67 | 3 | 32027621 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.93e-06 | 13 | 67 | 3 | 27777319 | |
| Pubmed | 1.93e-06 | 13 | 67 | 3 | 18848945 | ||
| Pubmed | 2.45e-06 | 14 | 67 | 3 | 37531413 | ||
| Interaction | YWHAH interactions | CEP170 CDC37 NOLC1 EHBP1 DLG5 MAP2 TEX2 PRRC2C CCDC18 CKAP5 BOD1L1 CGNL1 DNAH7 HSPA4 CCDC39 SNX2 EPB41L2 | 7.76e-08 | 1102 | 67 | 17 | int:YWHAH |
| Interaction | NAA40 interactions | CEP170 CDC37 NOLC1 EHBP1 MAP1B CDK12 PRRC2C STEEP1 DDX42 MKI67 CKAP5 BOD1L1 CGNL1 HSPA4 EPB41L2 | 5.66e-07 | 978 | 67 | 15 | int:NAA40 |
| Interaction | SMC5 interactions | BLM CEP170 NOLC1 MAP1B BAZ2B CDK12 PRRC2C ZNF644 STEEP1 DDX42 MKI67 BOD1L1 CHD7 DGCR8 HNRNPC | 7.49e-07 | 1000 | 67 | 15 | int:SMC5 |
| Interaction | PHLPP1 interactions | 1.52e-06 | 333 | 67 | 9 | int:PHLPP1 | |
| Interaction | TERF2IP interactions | BLM CDK12 ZNF644 STEEP1 DDX42 MKI67 BOD1L1 CHD7 DGCR8 HSPA4 PHC1 | 1.89e-06 | 552 | 67 | 11 | int:TERF2IP |
| Interaction | YWHAG interactions | CEP170 CDC37 NOLC1 EHBP1 DLG5 MAP2 CDK12 PRRC2C CCDC18 CKAP5 BOD1L1 CGNL1 DNAH7 HSPA4 SNX2 EPB41L2 | 2.37e-06 | 1248 | 67 | 16 | int:YWHAG |
| Interaction | TOMM20L interactions | 4.14e-06 | 10 | 67 | 3 | int:TOMM20L | |
| Interaction | ARMC10 interactions | 6.78e-06 | 37 | 67 | 4 | int:ARMC10 | |
| Interaction | IGLL1 interactions | 7.56e-06 | 12 | 67 | 3 | int:IGLL1 | |
| Interaction | CNTNAP2 interactions | 1.42e-05 | 158 | 67 | 6 | int:CNTNAP2 | |
| Interaction | KLHL35 interactions | 1.55e-05 | 15 | 67 | 3 | int:KLHL35 | |
| Interaction | HECTD1 interactions | BLM CEP170 NOLC1 MAP1B LRRC31 CDK12 PRRC2C MKI67 CKAP5 CKAP2L EXOC1 DGCR8 HSPA4 | 1.80e-05 | 984 | 67 | 13 | int:HECTD1 |
| Interaction | LINC00240 interactions | 1.91e-05 | 16 | 67 | 3 | int:LINC00240 | |
| Interaction | ZFAND3 interactions | 2.31e-05 | 17 | 67 | 3 | int:ZFAND3 | |
| Interaction | MIEF1 interactions | 2.48e-05 | 51 | 67 | 4 | int:MIEF1 | |
| Interaction | SIRT7 interactions | BLM CEP170 NOLC1 MAP1B PRRC2C DDX42 MKI67 CKAP5 CHD7 HSPA4 EPB41L2 | 3.14e-05 | 744 | 67 | 11 | int:SIRT7 |
| Interaction | CAVIN1 interactions | 5.16e-05 | 292 | 67 | 7 | int:CAVIN1 | |
| Interaction | SOX2 interactions | CEP170 DLG5 MAP1B BAZ2B CDK12 GLI3 ZNF644 TRPS1 CKAP5 CKAP2L PABPC4L BOD1L1 CHD7 DGCR8 HNRNPC | 5.23e-05 | 1422 | 67 | 15 | int:SOX2 |
| Interaction | CEBPD interactions | 5.38e-05 | 62 | 67 | 4 | int:CEBPD | |
| Interaction | GPD1 interactions | 5.93e-05 | 23 | 67 | 3 | int:GPD1 | |
| Interaction | DISC1 interactions | 8.59e-05 | 429 | 67 | 8 | int:DISC1 | |
| Interaction | PPIC interactions | 8.64e-05 | 26 | 67 | 3 | int:PPIC | |
| Interaction | PARP1 interactions | BLM CEP170 CDC37 NOLC1 LRRC31 ZNF644 MKI67 CHD7 DGCR8 CGNL1 HSPA4 SNX2 EPB41L2 PHC1 | 8.90e-05 | 1316 | 67 | 14 | int:PARP1 |
| Interaction | ERG interactions | 9.76e-05 | 223 | 67 | 6 | int:ERG | |
| Interaction | GBF1 interactions | 1.06e-04 | 442 | 67 | 8 | int:GBF1 | |
| Interaction | PSG5 interactions | 1.08e-04 | 5 | 67 | 2 | int:PSG5 | |
| Interaction | KLF8 interactions | 1.09e-04 | 329 | 67 | 7 | int:KLF8 | |
| Interaction | CTTN interactions | 1.20e-04 | 450 | 67 | 8 | int:CTTN | |
| Interaction | CSNK2A2 interactions | CEP170 CDC37 NOLC1 PRRC2C GLI3 MKI67 PLA2G4A HNRNPC EPB41L2 PHC1 | 1.22e-04 | 718 | 67 | 10 | int:CSNK2A2 |
| Interaction | CYLD interactions | CEP170 CDC37 DLG5 MAP1B PRRC2C CKAP5 RNF213 HSPA4 HNRNPC SNX2 BICD1 | 1.25e-04 | 868 | 67 | 11 | int:CYLD |
| Interaction | TDRKH interactions | 1.32e-04 | 78 | 67 | 4 | int:TDRKH | |
| Interaction | TERF2 interactions | 1.33e-04 | 340 | 67 | 7 | int:TERF2 | |
| Interaction | COX16 interactions | 1.48e-04 | 31 | 67 | 3 | int:COX16 | |
| Interaction | OFD1 interactions | 1.51e-04 | 347 | 67 | 7 | int:OFD1 | |
| Interaction | CC2D1A interactions | 1.51e-04 | 152 | 67 | 5 | int:CC2D1A | |
| Interaction | PPIA interactions | BLM CEP170 CDC37 DLG5 MAP1B CDK12 STEEP1 MKI67 CKAP2L DMD HNRNPC | 1.53e-04 | 888 | 67 | 11 | int:PPIA |
| Interaction | XIAP interactions | 1.59e-04 | 244 | 67 | 6 | int:XIAP | |
| Interaction | KCTD13 interactions | CEP170 CDC37 MAP1B MAP2 PRRC2C PPP1R9A CKAP5 EXOC1 CGNL1 DMD HSPA4 HNRNPC SNX2 EPB41L2 | 1.64e-04 | 1394 | 67 | 14 | int:KCTD13 |
| Interaction | ASF1A interactions | 1.78e-04 | 249 | 67 | 6 | int:ASF1A | |
| Interaction | SASS6 interactions | 1.87e-04 | 159 | 67 | 5 | int:SASS6 | |
| Interaction | NHLH1 interactions | 2.11e-04 | 88 | 67 | 4 | int:NHLH1 | |
| Interaction | MIEF2 interactions | 2.13e-04 | 35 | 67 | 3 | int:MIEF2 | |
| Interaction | XRCC6 interactions | BLM CDC37 MAP1B LRRC31 CDK12 STEEP1 DDX42 MKI67 BOD1L1 CHD7 DGCR8 | 2.25e-04 | 928 | 67 | 11 | int:XRCC6 |
| Interaction | H3C3 interactions | 2.29e-04 | 495 | 67 | 8 | int:H3C3 | |
| Interaction | YAP1 interactions | CEP170 MAP2 CDK12 PRRC2C STEEP1 CKAP5 BOD1L1 DGCR8 HSPA4 HNRNPC SNX2 EPB41L2 | 2.33e-04 | 1095 | 67 | 12 | int:YAP1 |
| Interaction | PALS2 interactions | 2.61e-04 | 93 | 67 | 4 | int:PALS2 | |
| Interaction | KIF15 interactions | 2.72e-04 | 94 | 67 | 4 | int:KIF15 | |
| Interaction | MECP2 interactions | BLM CEP170 NOLC1 DLG5 MAP1B MAP2 CDK12 DDX42 MKI67 CHD7 DGCR8 HNRNPC EPB41L2 | 2.76e-04 | 1287 | 67 | 13 | int:MECP2 |
| Interaction | DYNLL1 interactions | 2.80e-04 | 510 | 67 | 8 | int:DYNLL1 | |
| Interaction | YWHAQ interactions | CEP170 CDC37 NOLC1 DLG5 MAP2 CCDC18 CGNL1 DNAH7 HSPA4 HNRNPC SNX2 EPB41L2 | 2.83e-04 | 1118 | 67 | 12 | int:YWHAQ |
| Interaction | MAPRE1 interactions | 2.95e-04 | 514 | 67 | 8 | int:MAPRE1 | |
| Interaction | HSP90AB1 interactions | CDC37 MAP1B BAZ2B PRRC2C CKAP5 TRIM8 PLA2G4A BOD1L1 CGNL1 HSPA4 EPB41L2 | 3.01e-04 | 960 | 67 | 11 | int:HSP90AB1 |
| Interaction | ANKRD30A interactions | 3.01e-04 | 8 | 67 | 2 | int:ANKRD30A | |
| Interaction | CCDC8 interactions | 3.08e-04 | 656 | 67 | 9 | int:CCDC8 | |
| Interaction | BMI1 interactions | 3.18e-04 | 659 | 67 | 9 | int:BMI1 | |
| Interaction | GRK5 interactions | 3.49e-04 | 182 | 67 | 5 | int:GRK5 | |
| Interaction | YWHAZ interactions | CEP170 CDC37 NOLC1 DLG5 MAP2 TEX2 ZNF644 CCDC18 CKAP5 CGNL1 CEP126 HSPA4 EPB41L2 | 3.50e-04 | 1319 | 67 | 13 | int:YWHAZ |
| Interaction | RBBP5 interactions | 3.81e-04 | 287 | 67 | 6 | int:RBBP5 | |
| Interaction | SUMO1 interactions | 3.81e-04 | 287 | 67 | 6 | int:SUMO1 | |
| Interaction | LHX1 interactions | 3.85e-04 | 103 | 67 | 4 | int:LHX1 | |
| Interaction | STIL interactions | 4.25e-04 | 190 | 67 | 5 | int:STIL | |
| Interaction | STK36 interactions | 4.51e-04 | 45 | 67 | 3 | int:STK36 | |
| Interaction | SFN interactions | 4.54e-04 | 692 | 67 | 9 | int:SFN | |
| Interaction | PPP1CA interactions | 4.74e-04 | 696 | 67 | 9 | int:PPP1CA | |
| Interaction | COIL interactions | 4.75e-04 | 552 | 67 | 8 | int:COIL | |
| Interaction | TRIO interactions | 4.78e-04 | 109 | 67 | 4 | int:TRIO | |
| Interaction | GSTA2 interactions | 4.82e-04 | 10 | 67 | 2 | int:GSTA2 | |
| Interaction | KLF16 interactions | 5.16e-04 | 425 | 67 | 7 | int:KLF16 | |
| Interaction | RNF43 interactions | 5.31e-04 | 427 | 67 | 7 | int:RNF43 | |
| Interaction | NPM1 interactions | PIKFYVE CDC37 AKAP5 IMPG1 MAP1B LRRC31 PRRC2C MKI67 ANKRD30A HSPA4 HNRNPC BICD1 | 5.40e-04 | 1201 | 67 | 12 | int:NPM1 |
| Interaction | GSK3B interactions | 5.57e-04 | 868 | 67 | 10 | int:GSK3B | |
| Interaction | DNAJB5 interactions | 5.66e-04 | 114 | 67 | 4 | int:DNAJB5 | |
| Interaction | KCNA3 interactions | CEP170 EHBP1 DLG5 MAP1B PRRC2C CKAP5 RNF213 BOD1L1 HSPA4 EPB41L2 | 5.73e-04 | 871 | 67 | 10 | int:KCNA3 |
| Interaction | TTPA interactions | 5.80e-04 | 49 | 67 | 3 | int:TTPA | |
| Interaction | NDC80 interactions | 5.93e-04 | 312 | 67 | 6 | int:NDC80 | |
| Interaction | SP100 interactions | 6.14e-04 | 206 | 67 | 5 | int:SP100 | |
| Interaction | PSG1 interactions | 6.53e-04 | 51 | 67 | 3 | int:PSG1 | |
| Interaction | SNX1 interactions | 6.99e-04 | 212 | 67 | 5 | int:SNX1 | |
| Interaction | DUXA interactions | 7.03e-04 | 12 | 67 | 2 | int:DUXA | |
| Interaction | RPA4 interactions | 7.43e-04 | 452 | 67 | 7 | int:RPA4 | |
| Interaction | PABPC4L interactions | 7.72e-04 | 54 | 67 | 3 | int:PABPC4L | |
| Interaction | SNW1 interactions | 7.86e-04 | 747 | 67 | 9 | int:SNW1 | |
| Interaction | H3-3A interactions | 8.01e-04 | 749 | 67 | 9 | int:H3-3A | |
| Interaction | YWHAE interactions | CEP170 CDC37 NOLC1 DLG5 MAP1B CDK12 CCDC18 CKAP5 CGNL1 HSPA4 HNRNPC EPB41L2 | 8.02e-04 | 1256 | 67 | 12 | int:YWHAE |
| Interaction | SNRNP200 interactions | 8.23e-04 | 460 | 67 | 7 | int:SNRNP200 | |
| Interaction | CUX2 interactions | 8.29e-04 | 13 | 67 | 2 | int:CUX2 | |
| Interaction | NUAK2 interactions | 8.58e-04 | 56 | 67 | 3 | int:NUAK2 | |
| Interaction | GSK3A interactions | 8.66e-04 | 464 | 67 | 7 | int:GSK3A | |
| Interaction | AURKB interactions | 8.96e-04 | 761 | 67 | 9 | int:AURKB | |
| Interaction | PAWR interactions | 8.99e-04 | 129 | 67 | 4 | int:PAWR | |
| Interaction | BAG5 interactions | 9.41e-04 | 341 | 67 | 6 | int:BAG5 | |
| Interaction | PRG4 interactions | 9.66e-04 | 14 | 67 | 2 | int:PRG4 | |
| Interaction | PHF21A interactions | 9.70e-04 | 343 | 67 | 6 | int:PHF21A | |
| Interaction | PML interactions | BLM CEP170 NOLC1 CASP8AP2 MAP1B STEEP1 DDX42 RNF213 FNBP1L EPB41L2 | 9.71e-04 | 933 | 67 | 10 | int:PML |
| Interaction | MAPRE3 interactions | 1.01e-03 | 230 | 67 | 5 | int:MAPRE3 | |
| Interaction | MYB interactions | 1.01e-03 | 133 | 67 | 4 | int:MYB | |
| Interaction | RHBDD1 interactions | 1.01e-03 | 346 | 67 | 6 | int:RHBDD1 | |
| Interaction | BAG2 interactions | 1.03e-03 | 622 | 67 | 8 | int:BAG2 | |
| Interaction | DNAJC17 interactions | 1.04e-03 | 134 | 67 | 4 | int:DNAJC17 | |
| Interaction | KDM1A interactions | EHBP1 CASP8AP2 DLG5 ZNF644 TRPS1 CKAP5 EXOC1 CHD7 HNRNPC PHC1 | 1.04e-03 | 941 | 67 | 10 | int:KDM1A |
| Cytoband | 3q26.33 | 5.20e-04 | 23 | 67 | 2 | 3q26.33 | |
| Cytoband | 9p13.1 | 5.67e-04 | 24 | 67 | 2 | 9p13.1 | |
| Cytoband | 14q23.3 | 6.67e-04 | 26 | 67 | 2 | 14q23.3 | |
| Cytoband | 17q23.3 | 8.89e-04 | 30 | 67 | 2 | 17q23.3 | |
| Cytoband | 1p22.1 | 1.01e-03 | 32 | 67 | 2 | 1p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 1.08e-03 | 137 | 67 | 3 | chr1p22 | |
| Cytoband | 10q11.22 | 1.66e-03 | 41 | 67 | 2 | 10q11.22 | |
| Cytoband | 19q13.2 | 1.81e-03 | 164 | 67 | 3 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q34 | 1.99e-03 | 45 | 67 | 2 | chr2q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q26 | 3.94e-03 | 216 | 67 | 3 | chr3q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 5.44e-03 | 75 | 67 | 2 | chr1q31 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 9.92e-07 | 11 | 34 | 3 | 1315 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.35e-03 | 29 | 34 | 2 | 396 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.51e-03 | 163 | 34 | 3 | 590 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.70e-03 | 181 | 34 | 3 | 694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | BLM CEP170 PIKFYVE EHBP1 MAP1B BAZ2B PRRC2C DDX42 CKAP5 FNBP1L DMD SNX2 BICD1 | 2.18e-07 | 856 | 67 | 13 | M4500 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.92e-06 | 35 | 67 | 4 | MM757 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.82e-06 | 466 | 67 | 9 | M13522 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 1.24e-05 | 200 | 67 | 6 | M8997 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.48e-05 | 467 | 67 | 8 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.20e-05 | 484 | 67 | 8 | MM999 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 4.13e-05 | 75 | 67 | 4 | MM605 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 4.27e-05 | 656 | 67 | 9 | M18979 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CEP170 NOLC1 CASP8AP2 CDK12 PRRC2C DDHD1 CCDC18 MKI67 CKAP5 RNF213 PABPC4L DMD HNRNPC | 4.89e-05 | 1407 | 67 | 13 | M14427 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 5.64e-05 | 680 | 67 | 9 | MM456 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 6.37e-05 | 164 | 67 | 5 | M13108 | |
| Coexpression | LIAO_METASTASIS | 6.91e-05 | 540 | 67 | 8 | M13809 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 7.51e-05 | 32 | 67 | 3 | MM668 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 7.51e-05 | 32 | 67 | 3 | MM2 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 7.51e-05 | 32 | 67 | 3 | M1558 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 1.11e-04 | 578 | 67 | 8 | M2368 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | BLM CASP8AP2 CCDC18 MKI67 CKAP5 CKAP2L CHD7 DGCR8 EPB41L2 PHC1 | 1.29e-04 | 939 | 67 | 10 | M45768 |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 1.31e-04 | 191 | 67 | 5 | M40019 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 1.38e-04 | 597 | 67 | 8 | MM1309 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | 1.62e-04 | 200 | 67 | 5 | M5812 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 2.54e-04 | 48 | 67 | 3 | MM531 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | BLM CASP8AP2 MAP1B GLI3 ZNF644 TRPS1 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 FNBP1L CEP126 DMD HSPA4 PHC1 BICD1 | 2.07e-08 | 1060 | 67 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | GLI3 ZNF644 TRPS1 CCDC18 MKI67 CKAP5 CKAP2L PLA2G4A CEP126 HSPA4 | 3.12e-08 | 298 | 67 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BLM CASP8AP2 GLI3 CCDC18 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 HSPA4 | 4.66e-08 | 311 | 67 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BLM NOLC1 CASP8AP2 MAP1B MAP2 GLI3 ZNF644 TRPS1 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 FNBP1L CEP126 DMD HSPA4 PHC1 BICD1 | 7.15e-08 | 1459 | 67 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.05e-07 | 255 | 67 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | BLM CASP8AP2 PIGH MAP2 GLI3 ZNF644 TRPS1 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 FNBP1L CEP126 HSPA4 ZNF654 PHC1 | 2.29e-07 | 1252 | 67 | 17 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | BLM CASP8AP2 MAP1B MAP2 GLI3 ZNF644 TRPS1 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 FNBP1L CEP126 DMD HSPA4 PHC1 BICD1 | 2.42e-07 | 1414 | 67 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BLM NOLC1 CASP8AP2 MAP1B MAP2 GLI3 CCDC18 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 DMD HSPA4 BICD1 | 3.37e-07 | 989 | 67 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | MAP2 GLI3 TRPS1 CCDC18 MKI67 CKAP5 CKAP2L RNF213 CHD7 FNBP1L HSPA4 | 3.68e-07 | 492 | 67 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 6.74e-07 | 232 | 67 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CASP8AP2 MAP1B CDK12 PRRC2C GLI3 CCDC18 CKAP5 CHD7 CEP126 HSPA4 PHC1 | 7.96e-07 | 532 | 67 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | GLI3 TRPS1 CCDC18 MKI67 CKAP5 CKAP2L RNF213 BOD1L1 FNBP1L HSPA4 | 9.64e-07 | 432 | 67 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | BLM NOLC1 CASP8AP2 GLI3 ZNF644 TRPS1 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 FNBP1L CEP126 HSPA4 ZNF654 BICD1 | 1.11e-06 | 1241 | 67 | 16 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BLM NOLC1 CASP8AP2 GLI3 ZNF644 TRPS1 MKI67 CKAP5 CKAP2L BOD1L1 FNBP1L CEP126 DMD HSPA4 PHC1 BICD1 | 1.32e-06 | 1257 | 67 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.97e-06 | 186 | 67 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | EHBP1 AKAP5 MAP2 GLI3 TRPS1 CCDC18 MKI67 CKAP2L PLA2G4A RNF213 PABPC4L EPB41L2 | 4.99e-06 | 777 | 67 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | BLM NOLC1 CASP8AP2 GLI3 ZNF644 TRPS1 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 FNBP1L CEP126 HSPA4 ZNF654 BICD1 | 9.70e-06 | 1468 | 67 | 16 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BLM MAP2 GLI3 TRPS1 CCDC18 MKI67 CKAP5 CKAP2L RNF213 BOD1L1 CHD7 FNBP1L HSPA4 | 1.10e-05 | 989 | 67 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.59e-05 | 469 | 67 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | DLG5 GLI3 ZNF644 TRPS1 CCDC18 MKI67 CKAP5 CKAP2L PLA2G4A RNF213 HSPA4 | 1.95e-05 | 744 | 67 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.36e-05 | 493 | 67 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.55e-05 | 498 | 67 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.62e-05 | 629 | 67 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.19e-05 | 192 | 67 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.90e-05 | 199 | 67 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.23e-05 | 298 | 67 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | GLI3 ZNF644 TRPS1 CCDC18 MKI67 CKAP5 CKAP2L PLA2G4A CHD7 CGNL1 CEP126 HSPA4 | 4.96e-05 | 979 | 67 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.50e-05 | 71 | 67 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 MAP1B MAP2 MKI67 CKAP5 CKAP2L BOD1L1 CHD7 FNBP1L CEP126 DMD HSPA4 PHC1 BICD1 | 7.84e-05 | 1370 | 67 | 14 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.54e-04 | 492 | 67 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.66e-04 | 259 | 67 | 6 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.81e-04 | 89 | 67 | 4 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.81e-04 | 89 | 67 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.05e-04 | 654 | 67 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CASP8AP2 MAP1B MAP2 GLI3 TRPS1 CCDC18 CKAP5 CHD7 DMD HSPA4 BICD1 | 2.36e-04 | 983 | 67 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.52e-04 | 97 | 67 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | BLM CASP8AP2 DLG5 GLI3 TRPS1 PLA2G4A RNF213 PABPC4L CHD7 DNAH7 | 2.52e-04 | 827 | 67 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.62e-04 | 831 | 67 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 3.68e-04 | 423 | 67 | 7 | GSM791126_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 4.14e-04 | 46 | 67 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 4.41e-04 | 436 | 67 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.18e-04 | 209 | 67 | 5 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.18e-04 | 209 | 67 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.30e-04 | 118 | 67 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 5.94e-04 | 52 | 67 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.15e-04 | 331 | 67 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 6.39e-04 | 124 | 67 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_4 | 7.48e-04 | 13 | 67 | 2 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 7.58e-04 | 783 | 67 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | CASP8AP2 TRPS1 CCDC18 MKI67 CKAP2L RNF213 BOD1L1 CHD7 DMD HSPA4 | 9.35e-04 | 978 | 67 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 9.48e-04 | 61 | 67 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.66e-04 | 240 | 67 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 9.79e-04 | 139 | 67 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 9.95e-04 | 986 | 67 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | 1.06e-03 | 994 | 67 | 10 | Facebase_RNAseq_e8.5_Floor Plate_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.08e-03 | 246 | 67 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.18e-03 | 834 | 67 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 1.24e-03 | 148 | 67 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 1.40e-03 | 388 | 67 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 1.44e-03 | 858 | 67 | 9 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 1.62e-03 | 19 | 67 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 1.85e-03 | 410 | 67 | 6 | GSM791122_500 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-07 | 194 | 67 | 6 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.37e-07 | 198 | 67 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.54e-07 | 199 | 67 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.54e-07 | 199 | 67 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 5.70e-07 | 200 | 67 | 6 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 5.70e-07 | 200 | 67 | 6 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.70e-07 | 200 | 67 | 6 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-06 | 171 | 67 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-06 | 171 | 67 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-06 | 174 | 67 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-06 | 183 | 67 | 5 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-06 | 185 | 67 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-06 | 187 | 67 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.95e-06 | 190 | 67 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 191 | 67 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 191 | 67 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 192 | 67 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.07e-05 | 193 | 67 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 193 | 67 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-05 | 193 | 67 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 194 | 67 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.13e-05 | 195 | 67 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-05 | 197 | 67 | 5 | 6de02b02fcdfcab1c1b0f4a4c75677410bc55688 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 197 | 67 | 5 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.21e-05 | 198 | 67 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-05 | 198 | 67 | 5 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 199 | 67 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.27e-05 | 200 | 67 | 5 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-05 | 200 | 67 | 5 | 3d134ae3c48ff4d1849db4fbe44ff73fb6c8c779 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-05 | 200 | 67 | 5 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-05 | 200 | 67 | 5 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.92e-05 | 126 | 67 | 4 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.92e-05 | 126 | 67 | 4 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 5.59e-05 | 138 | 67 | 4 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.04e-04 | 162 | 67 | 4 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 165 | 67 | 4 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 167 | 67 | 4 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-04 | 167 | 67 | 4 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 168 | 67 | 4 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 168 | 67 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 169 | 67 | 4 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 169 | 67 | 4 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 169 | 67 | 4 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 169 | 67 | 4 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 169 | 67 | 4 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 171 | 67 | 4 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-04 | 172 | 67 | 4 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 172 | 67 | 4 | 29c8510f26527d487d0fc3543102d067cdb281a6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 173 | 67 | 4 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 173 | 67 | 4 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 174 | 67 | 4 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 67 | 4 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 67 | 4 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 67 | 4 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 175 | 67 | 4 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 175 | 67 | 4 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 175 | 67 | 4 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 1.46e-04 | 177 | 67 | 4 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-04 | 177 | 67 | 4 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-04 | 177 | 67 | 4 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 178 | 67 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.49e-04 | 178 | 67 | 4 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.53e-04 | 179 | 67 | 4 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 179 | 67 | 4 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-04 | 179 | 67 | 4 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.53e-04 | 179 | 67 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 179 | 67 | 4 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 180 | 67 | 4 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-04 | 180 | 67 | 4 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-04 | 180 | 67 | 4 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 1.56e-04 | 180 | 67 | 4 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-04 | 180 | 67 | 4 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 181 | 67 | 4 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 182 | 67 | 4 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-04 | 182 | 67 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 183 | 67 | 4 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.66e-04 | 183 | 67 | 4 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.66e-04 | 183 | 67 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 184 | 67 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 184 | 67 | 4 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.73e-04 | 185 | 67 | 4 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 185 | 67 | 4 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-04 | 185 | 67 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.73e-04 | 185 | 67 | 4 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 185 | 67 | 4 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-04 | 185 | 67 | 4 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-04 | 186 | 67 | 4 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 186 | 67 | 4 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 1.77e-04 | 186 | 67 | 4 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 186 | 67 | 4 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 186 | 67 | 4 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.77e-04 | 186 | 67 | 4 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.77e-04 | 186 | 67 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 187 | 67 | 4 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 187 | 67 | 4 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 187 | 67 | 4 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 187 | 67 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-04 | 188 | 67 | 4 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.84e-04 | 188 | 67 | 4 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.84e-04 | 188 | 67 | 4 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| Computational | Neighborhood of CDKN1C | 1.75e-04 | 27 | 44 | 3 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 2.92e-04 | 32 | 44 | 3 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 3.82e-04 | 35 | 44 | 3 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 6.57e-04 | 42 | 44 | 3 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 8.59e-04 | 46 | 44 | 3 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.03e-03 | 49 | 44 | 3 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-03 | 50 | 44 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC | |
| Computational | Genes in the cancer module 192. | 1.10e-03 | 112 | 44 | 4 | MODULE_192 | |
| Computational | Genes in the cancer module 427. | 1.25e-03 | 116 | 44 | 4 | MODULE_427 | |
| Computational | Neighborhood of ITGA2 | 1.52e-03 | 56 | 44 | 3 | MORF_ITGA2 | |
| Drug | pP-8 | 2.51e-06 | 10 | 64 | 3 | CID000444681 | |
| Drug | geldanamycin | 9.21e-06 | 371 | 64 | 8 | ctd:C001277 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.26e-05 | 183 | 64 | 6 | 7498_DN | |
| Drug | 1-TRIM | 1.68e-05 | 18 | 64 | 3 | CID000001359 | |
| Disease | cD177 antigen measurement | 8.13e-06 | 18 | 65 | 3 | EFO_0021866 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 7.13e-05 | 6 | 65 | 2 | EFO_0801907 | |
| Disease | pancreatic hormone measurement | 2.13e-04 | 10 | 65 | 2 | EFO_0020621 | |
| Disease | neuroimaging measurement | 5.37e-04 | 1069 | 65 | 9 | EFO_0004346 | |
| Disease | Colorectal Carcinoma | 8.81e-04 | 702 | 65 | 7 | C0009402 | |
| Disease | non-high density lipoprotein cholesterol measurement | 9.65e-04 | 713 | 65 | 7 | EFO_0005689 | |
| Disease | Immunologic Deficiency Syndromes | 1.17e-03 | 23 | 65 | 2 | C0021051 | |
| Disease | remnant cholesterol measurement | 1.77e-03 | 108 | 65 | 3 | EFO_0010815 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTKSSSSGAREKMEK | 976 | Q5SW79 | |
| EKMEKKTKSRSTDVG | 986 | Q5SW79 | |
| EKSQEVSSKSGSMKD | 131 | Q9NYV4 | |
| VTSLEKTTKESGEKM | 466 | Q96G01 | |
| SDTEGEKTSMKLNKT | 661 | Q9UIF8 | |
| KEMDKISGKLEDSTS | 946 | Q9BXX3 | |
| SVVEKTTSGMSKKSV | 346 | O75952 | |
| TTSGMSKKSVESVKL | 351 | O75952 | |
| TTVKEMSKKAPSEIS | 1001 | P11532 | |
| ESSKMVKQETSDKSV | 701 | Q8WYQ5 | |
| RSSKTEKKDKVMSTS | 1006 | Q9UKL3 | |
| MSSRSVKKQKESGEE | 806 | Q9P2D1 | |
| MEATGTDEVDKLKTK | 1 | Q96DT6 | |
| KEITEKTMSVEEKAT | 361 | Q9UFE4 | |
| SSSEEEKTKKMVATT | 431 | Q14978 | |
| MTEGSDEKKSVKTVN | 126 | Q8IWA4 | |
| MEAQSHSSTTTEKKK | 1 | P10071 | |
| SVKKDETNVKMESEG | 241 | P07910 | |
| DTKMSISEGTVSDKS | 1516 | P46821 | |
| SEEMETSQAGSKDKK | 546 | P34932 | |
| ESGDKKMKEITETVT | 56 | B3EWG6 | |
| KKEKDGSSSTEMQLT | 291 | Q17R60 | |
| SSKMDKVDSKTDKTA | 906 | Q86XP3 | |
| MTTEVGSVSEVKKDS | 1 | O43491 | |
| ESGDKKMKEITETVT | 56 | B3EWG3 | |
| MSQTRKKTSSEGETK | 1 | Q6UY01 | |
| KSSTSEKKAANEEME | 461 | Q8TDM6 | |
| SHTKESMTNEKTTKV | 1721 | P46013 | |
| TLKMKDDSKTDTGIV | 2886 | Q8NFC6 | |
| LGSTDSQVKEKSTMK | 1611 | Q9Y2I7 | |
| SMDQTGSKSDKETEK | 1801 | Q14008 | |
| KVDFMETENSSSVKK | 1186 | P54132 | |
| ASKQESGKMDAKTTV | 301 | Q5T0N5 | |
| EKASNSSKLESEMTK | 561 | Q5T9S5 | |
| SKKEEEVKTATATLM | 491 | Q0VF96 | |
| KSMVNTKPEKTEEDS | 126 | Q16543 | |
| KKCEKTSETSTMRTT | 381 | Q9P2H0 | |
| MSSEQDKSASKEKSK | 1 | Q8WXX0 | |
| GITEEKSKSEESKRM | 321 | P24588 | |
| KAVTESSEQDMKSGT | 971 | Q8NDI1 | |
| FEVAKIKMTGTTKES | 426 | Q9NV70 | |
| TSKDSMEDEKKPVAS | 776 | Q8NEL9 | |
| KVMVSTEITDGKGSK | 1261 | Q8TDX9 | |
| TGKESSKSMTVEVSD | 401 | P11464 | |
| TLSVKVMTDSSGKSK | 216 | P0CB38 | |
| TFTVSSMKVGEKKEV | 106 | P47712 | |
| ESGDKKMKEITETVT | 56 | B3EWG5 | |
| SEANTSKEMKDKTSE | 356 | Q8N9W8 | |
| DTTKSVVIGTKDTMS | 541 | Q96Q06 | |
| MTKVKVGKEDSSSTE | 216 | O60749 | |
| KRTKDMGKFSSVTVS | 146 | Q9H5V9 | |
| TGKEISKSMTVKVSG | 401 | Q00887 | |
| SMSTGESSKEAQKVK | 646 | Q8IWB4 | |
| KETKAVSEMSTEIGT | 2156 | Q9Y520 | |
| KMTKETATTTEKTTE | 936 | Q92954 | |
| TSVEELAKKMESVKS | 621 | Q8IYA6 | |
| SMSTGESSKEAQKVK | 646 | Q5VYP0 | |
| AMETESSEKVGKETS | 3506 | Q63HN8 | |
| LAKSSEGETMTKTDK | 486 | Q9UHF7 | |
| SMSTGESSKEAQKVK | 646 | Q5TZJ5 | |
| STEPKTCIESMEKKT | 921 | Q8IZM8 | |
| SGKESTTFIEMGKVK | 106 | Q14442 | |
| KVMDEKSSLGEKAES | 671 | P78364 | |
| TMESLKADEGKKETS | 1141 | P11137 | |
| FMKDSVVGSSKKSAT | 571 | Q9H582 | |
| MSKAQTDKETSEEKP | 646 | Q8IWB9 | |
| DKTEDVSFMKNTKSV | 291 | Q9BZR9 | |
| SATGKESSKSMTVEV | 306 | Q15238 | |
| SKKTEKMTSTTAEGA | 1081 | Q9ULJ8 |